🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Comparison of olaparib vs. physician's choice of single agent standard of c...
Status
Completed
Location
Research Site
Start Date
2015-02-06
Trial ID
NCT02282020
Treatments Being Tested
This is a phase II/III randomized controlled trial to evaluate efficacy of ...
Status
Unknown
Location
N.N. Blokhin Cancer Research Center
Start Date
2019-09-01
Trial ID
NCT04055038
Treatments Being Tested
To compare outcomes between the CRS group and the control group in patients...
Status
Recruiting
Location
National Cancer Center, Korea
Start Date
2025-09-10
Trial ID
NCT07171528
Treatments Being Tested
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
Randomized phase 3 trial evaluating niraparib plus dostarlimab vs chemother...
Status
Unknown
Location
Azienda Ospedaliera Spedali Civili
Start Date
2020-12-01
Trial ID
NCT04679064
Treatments Being Tested
This study is a pilot study of biomarker-driven targeted therapy in patient...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2018-11-26
Trial ID
NCT03699449
This trial is a registrational Phase III, randomized, open-label, multicent...
Status
Not Yet Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2026-07
Trial ID
NCT07545460
Treatments Being Tested
Drugs used in chemotherapy use different ways to stop tumor cells from divi...
Status
Completed
Location
Gynecologic Oncology Group
Start Date
2001-01
Trial ID
NCT00011986
This phase II trial studies how well Avatar-directed chemotherapy works in ...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2015-07-21
Trial ID
NCT02312245
This randomized phase II/III trial studies how well cediranib maleate and o...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-05-03
Trial ID
NCT02502266